Damtix 200 mg/40 mg spot-on solution for dogs up to 4 kg
Damtix 200 mg/40 mg spot-on solution for dogs up to 4 kg
Authorised
This information is not available for this product.
Product identification
Medicine name:
Damtix 200 mg/40 mg spot-on solution for dogs up to 4 kg
DAMTIX 200 mg/40 mg Lösung zum Auftropfen für Hunde bis 4 kg
Active substance:
This information is not available for this product.
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 10 pipettes
- White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 6 pipettes
- White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 4 pipettes
- White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 3 pipettes
- White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 1 pipette
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Krka d.d. Novo Mesto
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- V7004634.00.00
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0663/001
Concerned member states:
-
Finland
-
France
-
Germany
-
Greece
-
Italy
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: